1/27
08:33 am
lbrx
LB Pharmaceuticals initiates Phase 2 trial of LB-102 [Yahoo! Finance]
Low
Report
LB Pharmaceuticals initiates Phase 2 trial of LB-102 [Yahoo! Finance]
1/26
08:00 am
lbrx
LB Pharmaceuticals Initiates Phase 2 ILLUMINATE-1 Trial in Bipolar Depression, Expanding LB-102 Development Program
Medium
Report
LB Pharmaceuticals Initiates Phase 2 ILLUMINATE-1 Trial in Bipolar Depression, Expanding LB-102 Development Program
1/21
08:00 am
lbrx
LB Pharmaceuticals Appoints Minako Pazdera, J.D., Ph.D. as General Counsel
Low
Report
LB Pharmaceuticals Appoints Minako Pazdera, J.D., Ph.D. as General Counsel
1/12
04:05 pm
lbrx
LB Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4)
Medium
Report
LB Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4)
1/10
05:43 am
lbrx
LB Pharmaceuticals (NASDAQ:LBRX) was upgraded by analysts at Roth Capital to a "strong-buy" rating.
Medium
Report
LB Pharmaceuticals (NASDAQ:LBRX) was upgraded by analysts at Roth Capital to a "strong-buy" rating.
1/9
05:03 am
lbrx
LB Pharmaceuticals (NASDAQ:LBRX) is now covered by analysts at Roth Capital. They set a "buy" rating on the stock.
Low
Report
LB Pharmaceuticals (NASDAQ:LBRX) is now covered by analysts at Roth Capital. They set a "buy" rating on the stock.
1/6
07:22 am
lbrx
LB Pharmaceuticals Strengthens Leadership Team with Key Appointments in Corporate Affairs and People & Culture [Yahoo! Finance]
Low
Report
LB Pharmaceuticals Strengthens Leadership Team with Key Appointments in Corporate Affairs and People & Culture [Yahoo! Finance]
1/6
07:00 am
lbrx
LB Pharmaceuticals Strengthens Leadership Team with Key Appointments in Corporate Affairs and People & Culture
Low
Report
LB Pharmaceuticals Strengthens Leadership Team with Key Appointments in Corporate Affairs and People & Culture
1/21
12:32 pm
lbrx
Form SCHEDULE 13G LB PHARMACEUTICALS INC Filed by: BlackRock, Inc.
Low
Report
Form SCHEDULE 13G LB PHARMACEUTICALS INC Filed by: BlackRock, Inc.
1/21
12:27 pm
lbrx
Form SCHEDULE 13G/A LB PHARMACEUTICALS INC Filed by: BlackRock Portfolio Management LLC
Low
Report
Form SCHEDULE 13G/A LB PHARMACEUTICALS INC Filed by: BlackRock Portfolio Management LLC
1/21
08:14 am
lbrx
Form SCHEDULE 13G LB PHARMACEUTICALS INC Filed by: JPMORGAN CHASE & CO
Low
Report
Form SCHEDULE 13G LB PHARMACEUTICALS INC Filed by: JPMORGAN CHASE & CO
12/31
05:00 pm
lbrx
Form SCHEDULE 13G LB PHARMACEUTICALS INC Filed by: Trails Edge Capital Partners, LP
Medium
Report
Form SCHEDULE 13G LB PHARMACEUTICALS INC Filed by: Trails Edge Capital Partners, LP
12/11
04:15 pm
lbrx
Form 4 LB PHARMACEUTICALS INC For: Dec 10 Filed by: Pai Panandiker Kaya Kamlesh
Medium
Report
Form 4 LB PHARMACEUTICALS INC For: Dec 10 Filed by: Pai Panandiker Kaya Kamlesh
11/18
06:58 pm
lbrx
Form 3 LB PHARMACEUTICALS INC For: Nov 10 Filed by: Pai Panandiker Kaya Kamlesh
Low
Report
Form 3 LB PHARMACEUTICALS INC For: Nov 10 Filed by: Pai Panandiker Kaya Kamlesh
11/13
08:15 am
lbrx
Form 8-K LB PHARMACEUTICALS INC For: Nov 10
Low
Report
Form 8-K LB PHARMACEUTICALS INC For: Nov 10
11/12
08:17 am
lbrx
Form 8-K LB PHARMACEUTICALS INC For: Nov 12
Medium
Report
Form 8-K LB PHARMACEUTICALS INC For: Nov 12
News Stats
All News
News Wires
Media Monitoring
SEC Edgar Filings
Upgrades
Downgrades
Initiated
Reiterated
Last Earnings
Last Earnings EPS
Next Earnings
Order Stats
Sub-Penny
Odd lot
Avg. bid-ask spread
Avg. bid-ask size
Shares at ask/bid
Off exchange
Main News & Impact Reports
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below:
Register